Contrast Induced Nephropathy (CIN) Completed Phase 4 Trials for Iodixanol (DB01249)

Also known as: Contrast Induced Nephropathy

IndicationStatusPhase
DBCOND0066353 (Contrast Induced Nephropathy (CIN))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00827788Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)Prevention